BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2147605)

  • 1. [Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma].
    Natali M; D'Aprile M; Tonini G; Leggio M; Vici P; Carpano S; Angelini F; Carassai A; Lopez M
    Clin Ter; 1990 Jul; 134(1):25-30. PubMed ID: 2147605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil.
    Nozue M; Isaka N; Maruyama T; Kawamoto T; Seino KI; Tanagichi H; Fukao K
    Oncol Rep; 2002; 9(1):93-6. PubMed ID: 11748463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM).
    Colucci G; Maiello E; Leo S; Giuliani F; Pedicini A; Pezzella G; Valori V; Galetta D; Contillo A; Prete F
    Anticancer Res; 1994; 14(5B):2157-62. PubMed ID: 7840516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer.
    Cure H; Chevalier V; Pezet D; Bousquet J; Focan C; Levi F; Garufi C; Chipponi J; Chollet P
    Anticancer Res; 2000; 20(6C):4649-53. PubMed ID: 11205195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer.
    Stabuc B; Markovic A; Plesnicar A; Cizej TE
    Neoplasma; 2000; 47(4):248-52. PubMed ID: 11043831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
    Hochster H; Chachoua A; Speyer J; Escalon J; Zeleniuch-Jacquotte A; Muggia F
    J Clin Oncol; 2003 Jul; 21(14):2703-7. PubMed ID: 12860947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocalcemia associated with 5-fluorouracil and low dose leucovorin in patients with advanced colorectal or gastric carcinomas.
    Kido Y; Okamura T; Tomikawa M; Yamamoto M; Shiraishi M; Okada Y; Kimura T; Sugimachi K
    Cancer; 1996 Oct; 78(8):1794-7. PubMed ID: 8859194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced breast cancer with 5-fluorouracil and high-dose folinic acid: preliminary results.
    Marini G; Marpicati P; Zaniboni A; Cervi GC; Gorni F; Simoncini E
    Chemioterapia; 1985 Apr; 4(2):135-8. PubMed ID: 3874000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer.
    Howell JD; Warren HW; Anderson JH; Kerr DJ; McArdle CS
    Eur J Surg; 1999 Jul; 165(7):652-8. PubMed ID: 10452259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.
    Xiong JP; Zhang L; Zhong LX; Qiu F; Xu J; Tao QS; Xiang XJ; Yu F; Tang XM
    Anticancer Drugs; 2007 Oct; 18(9):1103-7. PubMed ID: 17704661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fluorouracil as monotherapy or combined with folinic acid in the treatment of metastasizing colorectal carcinoma].
    Löffler TM; Korsten FW; Reis HE; Planker M; Burghardt F; Aulbert E; Lindemann W; Schröder M; Hausamen TU; Strohmeyer G
    Dtsch Med Wochenschr; 1992 Jun; 117(26):1007-13. PubMed ID: 1618109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
    Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M
    Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvements in palliative treatment of colorectal carcinoma].
    Wein A; Riedel C; Hanke B; Lampert S; Brückl W; Reingruber B; Hohenberger W; Hahn EG
    Dtsch Med Wochenschr; 2000 Feb; 125(5):121-5. PubMed ID: 10705885
    [No Abstract]   [Full Text] [Related]  

  • 19. Small vessel vasculitis related to 5-fluorouracil and folinic acid.
    Pellegrini F; Astorino S; Castaldi N; Fassone F; Pasquini P
    Eur J Dermatol; 2010; 20(6):862-3. PubMed ID: 20965807
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous 24-hour infusion of folinic acid does not increase the response rate of 5-fluorouracil but only the toxicity.
    Tsavaris N; Tzannou I; Karvounis N; Kosmidis P
    Oncology; 1992; 49(2):154-6. PubMed ID: 1574252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.